Search Results Search Sort by RelevanceMost Recent Letter to the Editor Oct 2017 Response to “What Should Physicians Do When They Disagree, Clinically and Ethically, with a Surrogate’s Wishes?” Petros Ioannou, MD, MSc, PhD Understanding the religious background of patients and their surrogates is essential to providing patient-centered care at the end of life. AMA J Ethics. 2017;19(10):1051-1053. doi: 10.1001/journalofethics.2017.19.10.corr3-1710. Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352. Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020;22(5):E358-364. doi: 10.1001/amajethics.2020.358. Case and Commentary Apr 2021 是否应该为了推动其他自由而去限制某种自由? Katherine J. Feder (理学硕士), Janice I. Firn(理学博士、注册硕士社会工作者), and Ryan Stork(医学博士) AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305. Case and Commentary Apr 2021 ¿Debería limitarse un tipo de libertad a favor de otro? Katherine J. Feder, MS, Janice I. Firn, PhD, and Ryan Stork, MD AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Letter to the Editor Oct 2017 Response to “What Should Physicians Do When They Disagree, Clinically and Ethically, with a Surrogate’s Wishes?” Petros Ioannou, MD, MSc, PhD Understanding the religious background of patients and their surrogates is essential to providing patient-centered care at the end of life. AMA J Ethics. 2017;19(10):1051-1053. doi: 10.1001/journalofethics.2017.19.10.corr3-1710.
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 Should Aggregate Patient Preference Data Be Used to Make Decisions on Behalf of Unrepresented Patients? Nathaniel Sharadin, PhD, MA Ethical and practical problems with preference modeling can undermine how reliably predictors can be used in high-stakes decisions. AMA J Ethics. 2019;21(7):E566-574. doi: 10.1001/amajethics.2019.566.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Case and Commentary May 2020 When a Patient Regrets Having Undergone a Carefully and Jointly Considered Treatment Plan, How Should Her Physician Respond? Luke V. Selby, MD, MS, Christopher T. Aquina, MD, MPH, and Timothy M. Pawlik, MD, PhD, MPH, MTS Whether a patient’s decisional regret constitutes a failure of shared decision making can depend on how a decision was made. AMA J Ethics. 2020;22(5):E352-357. doi: 10.1001/amajethics.2020.352.
Case and Commentary May 2020 Sliding-Scale Shared Decision Making for Patients With Reduced Capacity Tim Lahey, MD, MMSc and Glyn Elwyn, MD, PhD, MSc Shared decision making honors patient autonomy, particularly for preference-sensitive care decisions and even when patients have impaired decision-making capacity. AMA J Ethics. 2020;22(5):E358-364. doi: 10.1001/amajethics.2020.358.
Case and Commentary Apr 2021 是否应该为了推动其他自由而去限制某种自由? Katherine J. Feder (理学硕士), Janice I. Firn(理学博士、注册硕士社会工作者), and Ryan Stork(医学博士) AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305.
Case and Commentary Apr 2021 ¿Debería limitarse un tipo de libertad a favor de otro? Katherine J. Feder, MS, Janice I. Firn, PhD, and Ryan Stork, MD AMA J Ethics. 2021;E305-310. doi: 10.1001/amajethics.2021.305.